Overview

• Antibiotics – miracle medicines

• Antibiotic resistance – a critical global problem

• The link between antibiotic use and resistance

• Addressing antibiotic resistance

• The role of antimicrobial stewardship

• Prescribing and using antibiotics with care

Whenever they are used, antibiotics must be used with care.

The “miracle” of antibiotics

1. Armstrong GL et al, JAMA 1999;281(1):61-66

• Discovery of penicillin revolutionised treatment of infectious disease

• Increased life expectancy due to ability to prevent and treat infection

Crude mortality rates for

all causes, non infectious

causes and infectious

diseases over the period

1900-1996.

Antibiotics continue to save lives,

every day…

• Ability to control infection is critical to other

advances in medicine

– Neonatal care

– Transplantation

– Chemotherapy

– Immunosuppression

– Complex and routine surgery

– Obstetric care

– Intensive care interventions

But…antibiotics

are a limited resource

Increasing antibiotic resistance

Increased use of antibiotics

Decreasing pipeline of new antibiotics

Urgent call to action

2. Spellberg, B. et al. Clinical Infectious Diseases 2008; 46 (2):155-64

3. Gottlieb, T and Nimmo, G. Medical Journal of Australia 2011; 194 (6): 281-3

Emergence of antibiotic resistance

“It is not difficult to make microbes resistant to penicillin

in the laboratory by exposing them to concentrations not

sufficient to kill them, and the same thing has

occasionally happened in the body.”

Sir Alexander Fleming, 1945

The issue of antibiotic resistance was recognised

early in the ‘antibiotic era’. It threatens our ability to

control infection.

4. Sir Alexander Fleming, Nobel Lecture, December 1945

Emergence of antibiotic resistance Antibiotic resistance threatens ability to control infection

5. Pray LA Insight Pharma Reports 2008, in Looke D ‘The Real Threat of Antibiotic Resistance’ 2012

Resistance spreads rapidly

6. Centers for Disease Control and Prevention http://www.cdc.gov/hai/

Impact of resistance:

real people are affected

7. Glen’s story access at http://www.hha.org.au/ForHealthcareWorkers/education.aspx

8. Magiorakos, A. P., Srinivasan, A et al Clinical Infectious Diseases 2012; 18 (3); 268-81.

9. Roberts RR et al. Clinical Infectious Diseases 2009; 49:1175-84

• Increased morbidity/mortality

– Evidence across many

pathogens

• Pan drug resistant infections – Now being encountered

• Increased costs – $18-29,000 US/patient

– Excess length of stay 6.4 – 12.7

days/patient

Glen’s story

Antibiotic resistance:

a global problem…

10. World Health Organization 2014 Antimicrobial Resistance: Global Report on surveillance.

http://www.who.int/drugresistance/documents/surveillancereport/en/ Last accessed 21/9/14

Key findings: • Very high rates of resistance

observed for common bacteria that cause health care associated and community acquired infections (for example urinary tract, pneumonia) in all WHO regions.

• Significant gaps in surveillance.

• Urgent need to strengthen collaboration on global surveillance as the foundation of global strategies to address antimicrobial resistance (AMR).

...a problem in our region

High prevalence of drug resistance reported in clinically important pathogens including serious hospital acquired skin infections.

For example

• prevalence rates of 77.6% and 74.1% of methicillin-resistant S. aureus reported in Republic of Korea and Vietnam respectively.

• prevalence rates of 68–90% of gonorrhoea infections with reduced susceptibility and resistance to quinolones reported in Japan, Malaysia and Singapore.

11. WHO 2015. Action agenda for antimicrobial resistance in the Western Pacific Region. Access at:

http://www.wpro.who.int/entity/drug_resistance/policy/en/ last accessed 8 September 2015

Resistance (%ESBL)

in the Asia Pacific

region

Australia ECOL: 12% KPNE: 15% New Zealand

ECOL: 11% KPNE: 10%

Hong Kong ECOL: 46% KPNE: 23% India

ECOL: 78% KPNE: 64%

Indonesia ECOL: 71% KPNE: 64%

Japan† ECOL: 17% KPNE: 11%

Korea ECOL: 37% KPNE: 40%

Malaysia ECOL: 36% KPNE: 45%

Philippines ECOL: 47% KPNE: 23%

Singapore ECOL: 21% KPNE: 32%

Taiwan ECOL: 91% KPNE: 75%

12. Mendes et al., Antimicrob. Agents Chemother. 2013

13. Xiao et al, Drug Resist Updat, 2011 (2009 data)

14. Chong et al., EJCMID, 2011 (2009 data)

China* ECOL: 54% KPNE: 41%

Thailand* ECOL: 55% KPNE: 50%

Antibiotic resistance in our region

15 Looke DF, Gottlieb T, Jones CA, Paterson DL Med J Aust. 2013 Mar 18;198(5):243-.

16. Harris P, Paterson D, Rogers B Med J Aust. 2015 Facing the challenge of multidrug-resistant gram-negative bacilli in Australia.

Mar 16;202(5):243-7.

…and a problem here in Australia

Antibiotic resistance locally

What is happening in our health service

• Which infections are we seeing?

• What are our susceptibility and resistance

patterns ?

– [Insert hospital data]

– [Numbers of cases]

– [Examples of cases]

The link between use and resistance

Countries with high penicillin consumption also have high rates of

penicillin resistance in pneumococci

17. van de Sande-Bruinsma N et al. Emerging Infectious Diseases 2008; 14(11):1722-1730

Occurrence of penicillin-

nonsusceptible Streptococcus

pneumoniae (PNSP) versus

outpatient use of penicillins in

17 European countries.

Antibiotic usage varies Within the country there is variation in consumption of antibiotics, not easily accounted for by case-mix. .

Antimicrobial use in Australian hospitals: 2014 annual report of the National Antimicrobial Utilisation Surveillance Program

http://www.safetyandquality.gov.au/publications/antimicrobial-use-in-australian-hospitals-2014-report-of-the-national-antimicrobial-

utilisation-surveillance-program/

Overall antimicrobial usage rates (N=129) NAUSP 2014 *

Antibiotic usage varies Between hospitals consumption also varies. Annual carbapenem usage by AIHW* peer group (FY2014-15)

*Australian Institute of Health and Welfare

19. Data source: National Antimicrobial Utilisation Surveillance Program (NAUSP) – unpublished data

Antibiotic use in Australian Hospitals

30-40% of hospitalised patients are prescribed

antibiotics20,21

The 2014 NAPS* Report indicates that around one quarter

of antibiotics prescribed in Australian hospitals are

prescribed inappropriately21

Australian hospitals dispense higher volumes of

antibiotics than some other countries22

*Hospitals that participate in NAPS are provided with data on the appropriateness of

their own prescribing patterns for local quality improvement.

20. Duguid M, Cruickshank M (eds). Antimicrobial Stewardship in Australian Hospitals. Sydney: ACSQHC, 2011

21. Australian Commission on Safety and Quality in Health Care (2015). Antimicrobial prescribing practice in Australian

hospitals: results of the 2014 National Antimicrobial Prescribing Survey, ACSQHC, Sydney.

22. Antimicrobial use in Australian hospitals: 2014 report of the National Antimicrobial Utilisation Surveillance Program

What is inappropriate use ?

Inappropriate use includes:

• Using broad-spectrum antibiotics (such

as third generation cephalosporins,

carbapenems) when narrow-spectrum

antibiotics are effective

• Prescribing too low or too high a dose

of antibiotic

• Not prescribing according to

microbiology results

• Continuing treatment for longer than

necessary

• Omitting doses or delayed

administration.

Top reasons for inappropriate

use – NAPS 2014

Adding to the problem …

Antibiotics are a limited resource

Few new antibiotics

• majority developed pre 1970

• 3 new classes in 20 years

Global recognition that:

• new antibiotics are urgently

required

• need to conserve what we

have now

23: Adapted from Spellberg B et al. The epidemic of antibiotic resistant infections: A call to action for the medical community from the

Infectious Diseases Society of America. Clin Inf Dis 2008;48:155-64

24. Spellberg B New antibiotic development: barriers and opportunities in 2012. APUA Clinical Newsletter 2012; 30(1):8-10

The dwindling development of antibiotics…

number of US FDA Antibiotic approvals23

24

Antibiotic usage in our health service

• Insert local usage data if available

• Include information about

– Contributions to National Antimicrobial Usage

Surveillance Program (NAUSP)

What about antibiotic appropriateness in

our health service?

• Insert local prescribing data including

– Participation in the National Antimicrobial Prescribing

Survey, results and trends over time if relevant.

The National Antimicrobial Resistance (AMR) Strategy25

Responding to the threat of AMR

Seven objectives focused on

1. Awareness, education

2. Antimicrobial stewardship

3. Surveillance

4. Infection prevention and control

5. International management

6. Research and development

7. Governance

25. Commonwealth of Australia. National Antimicrobial Resistance Strategy. 2015. Access at: www.health.gov.au/amr

Addressing antibiotic resistance:

a multidisciplinary, comprehensive approach

Prevent and manage infections • Infection prevention and control

• Includes hand hygiene, standard and transmission-based precautions, environmental cleaning.

Prolong effectiveness of existing antibiotics • Antimicrobial stewardship

Addressing antibiotic resistance is

everybody’s business.

Antimicrobial stewardship (AMS)

Principles: • promote best clinical outcome for the treatment or prevention

of infection

• minimal toxicity to the patient

• minimal impact on resistance and other adverse events

• timely and optimal selection, dose and duration of an antimicrobial.

Requires team work at all levels:

• “everybody's business"

• executive and clinical leadership

• clinical team (doctors, nurses, pharmacists, allied health)

• consumers.

26. Nathwani D and Sneddon J. Practical Guide to Antimicrobial Stewardship.

Access at http://bsac.org.uk/news/practical-guide-to-antimicrobial-stewardship-in-hospitals/

Essential strategies for effective AMS

NSQHS Standards, Standard 3:

Antimicrobial Stewardship Criterion

27. National Safety & Quality Health Service Standards .Access at www.safetyandquality.gov.au/our-work/accreditation/nsqhss/

Actions required:

3.14.1 An AMS program is in place

3.14.2

The clinical workforce prescribing antimicrobials have access to endorsed Therapeutic Guidelines on antibiotic usage

3.14.3

Monitoring of antimicrobial usage & resistance is undertaken

3.14.4

Action is taken to improve effectiveness of your AMS program

Clinical Care Standard for AMS

What role do you play?

Nine statements describing best practice

for managing a patient who has, or is

suspected of having a bacterial infection,

regardless of setting.

• For consumers: describes the care

they can expect to receive

• For clinicians: provides support in the

delivery of care the patient is expecting

• For health services: systems are in

place to support clinicians in providing

the care that is expected by the patient

28. Australian Commission on Safety and Quality in Health Care. Antimicrobial Stewardship Clinical Care

Standard. Access at www.safetyandquality.gov.au/ccs

Antimicrobial Use and Resistance in Australia

• The AURA Project will establish a national antimicrobial

usage and resistance surveillance system by June 2016.

• Working with existing programs, such as NAPS and NAUSP,

will enhance capacity for surveillance and build new systems

such as the National Alert System for Critical Antimicrobial

Resistances (NASCAR).

• The key objective is to increase access to data for action

against AMR.

• Funded by the Australian Government Department of Health.

http://www.safetyandquality.gov.au/national-priorities/amr-and-au-surveillance-project/

Antimicrobial stewardship

in our hospital

• Multidisciplinary, team approach

• Local roles and responsibilities – Medicine, nursing, pharmacy

– Consumer participation

– Executive and clinical leaders

• Local processes for stewardship – Include local processes for

• seeking ID/micro consults

• guideline and formulary information

• pharmacy advice

• contacts

• other relevant information.

Our Health service tools and activities to

promote appropriate use of antibiotics

• Responsible committees – e.g. infection control, drug and therapeutics committees

• AMS team to coordinate activity

• Education – Local prescribing guidelines

– Therapeutic Guidelines: Antibiotic

– AMS Clinical Care Standard

• Policy – Formulary with restrictions and approval

• Access to expert prescribing advice – ID, micro, pharmacy

• Monitoring, audit and feedback – appropriateness, usage, indicators

• Who to contact?

29. Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2014.

Therapeutic Guidelines: Antibiotic

A quick note…

• Check hospital intranet

• Current Version 15

– released November 2014

• Learn more

– www.tg.org.au

– click ‘Products’, then ‘Antibiotic’

– summary of new information and major changes for version 15: www.tg.org.au/uploads/PDFs/Whats_New_in_Antibiotic15.pdf

Antibiotic Awareness Week 2015

• Coordinated by The Australian Commission on Safety and Quality in

Health Care

• National working group, “One Health” focus:

– Australian Government Department of Agriculture and Water Resources

– Australian Government Department of Health

– State and Territory Health representatives

– NPS MedicineWise

– Australian Veterinary Association.

• Supported by:

– Australasian College for Infection Prevention and Control

– Australasian Society for Infectious Diseases

– Australian Society for Antimicrobials

– Society of Hospital Pharmacists of Australia.

Australian Commission on Safety and Quality in Health Care

Antibiotics. Handle with Care.

The AMS Clinical Care Standard outlines evidenced-based approaches

for using antibiotics with care. Access at www.safetyandquality.gov.au/ccs

Antibiotic Awareness Week

What is happening in our health service ?

• Local activities, contacts

• Include information about local activities.

Fight antibiotic resistance:

take the pledge • NPS MedicineWise is asking consumers

and health professionals to take the pledge to fight antibiotic resistance

• Health professionals are encouraged to have the sometimes difficult conversations with patients when antibiotics are not appropriate

• Visit nps.org.au/aaw to download resources to use throughout AAW

• Join the conversation - tag @NPSMedicineWise or hashtag #AntibioticResistance on social media

World Health Organization (WHO)

First World Antibiotic Awareness Week

Antibiotics: Handle with Care

Antibiotics are a precious resource and should be preserved.

Aim of World Antibiotic Awareness Week:

• increase awareness of global antibiotic resistance

• encourage best practices among general public, health workers and policy makers to avoid further emergence and spread of antibiotic resistance.

• resources and more information available: – WHO international http://www.who.int/drugresistance/en/

– Who Western Pacific Regional Office http://www.wpro.who.int/topics/drug_resistance/en/

A global effort

Canada: Healthy Canadians Antibiotic

http://www.canada.ca/antibiotics

United States: Get Smart About Antibiotics

http://www.cdc.gov/GetSmart/

Europe: Antibiotic Awareness Day

http://ecdc.europa.eu/en/eaad/Pages/Home.aspx

Join the conversation

Monday 16 November • Australian Antibiotic

Awareness Week

• #ABxAus

Wednesday 18 November • A global Twitter chat involving

partner countries

• Organisations and experts participating

• #AntibioticResistance

“Never underestimate the

importance of consumer

groups and civil society in

combating antimicrobial

resistance. They are

important movers, shakers,

and front-line players,

especially in this age of

social media.” Dr Margaret Chan

30

30. Dr Margaret Chan, Keynote address at the conference on Combating antimicrobial resistance: time for action

Copenhagen, Denmark 14 March 2012 . http://www.who.int/dg/speeches/2012/amr_20120314/en/ last accessed 22/9/14

Remember…

Antibiotics are a limited, precious resource

• Antibiotics are a precious resource that could be lost.

• Antibiotic resistance is happening now – it is a worldwide

problem that affects human and animal health.

• Antibiotic resistance happens when bacteria stops an

antibiotic from working effectively – meaning some

infections may be impossible to treat.

• Misuse of antibiotics contributes to antibiotic resistance.

• Few new antibiotics are being developed to help solve this

problem.

• To preserve the miracle of antibiotics, whenever they are

used, antibiotics must be used with care.

Acknowledgements

• Australian Commission on Safety and Quality in Health Care

– Antibiotic Awareness Week working group members

– AMS Jurisdictional Network

– AMS Advisory Committee

• Australian Group on Antimicrobial Resistance

• National Antimicrobial Utilisation Surveillance Program

• National Centre for Antimicrobial Stewardship

• European Centre for Disease Prevention and Control

• World Health Organization (WHO)

• References available at www.safetyandquality.gov.au/aaw

This presentation is intended to be used by health professionals, and reasonable care has been taken to ensure that the

information is correct at the date of creation. It is intended to be used in its original version.

The original version along with a complete list of references can be downloaded from the Commission web page:

www.safetyandquality.gov.au/aaw